Vision and Business idea
Our vision is to develop new and effective candidate drugs to improve quality of life for patients suffering from cancer, COPD/asthma and cardiovascular diseases.
We strive to be a prefered partner for academic researchers, biotech and global pharma companies. Respiratorius maintains a unique and competitive edge within the value chain from the early academic research to a new drug on the market.
Respiratorius business idea is to develop propriety candidate drugs that in preclinical studies show superior results compared to the gold standard.